Quest Partners »

Halozyme Therapeutics shares owned by Quest Partners

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Quest Partners from 13F filings

Historical chart of Quest Partners investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Quest Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Quest Partners

Quarter filed Position value Share count Share price at filing
2025-09-30 $2.9M 39k 73.34
2025-06-30 $276k 5.3k 52.02
2025-03-31 $11k 175 63.81
2024-12-31 $8.4k 175 47.81
2024-09-30 $561k 9.8k 57.24
2024-06-30 $35k 659 52.36
2024-03-31 $197k 4.8k 40.68
2023-12-31 $436k 12k 36.96